Immune Design is Profiled in this Database

Updated At 27 Jan, 2012

Start Free 7 Day Trial Now
Partial description of this company
Two novel technologies that boost immune responses, including a synthetic toll-like receptor agonist for use as an adjuvant to vaccines , and a viral vector that targets immature dendritic cells

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Immune Design plus 5035 other startups.

Start Free 7 Day Trial Now

Learn More About Immune Design

Technology/product details

Revenue projections

Capital raised to date

Growth strategy


Our Clients